Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update


#223510

20pages

GlobalData

$ 750

In Stock


Oryzon Genomics S.A. (Oryzon) is a biopharmaceutical company. The company develops therapies and biological solutions for cancer and neurodegenerative diseases. It concentrates on the exploitation of biomarkers identified through genomics and proteomics in diagnostics, personalized medicine and therapy fields. Oryzons diagnostic products include GynEC-DX for endometrial cancer; Cxbladder for bladder cancer; and ColoBRAF for colorectal cancer. The company produces NCEs and monoclonal antibodies for neurogeneration and cancer. It collaborates with Eurostarts, Mind, Dendria, Oncologica, Alzheimer Drug Discovery Foundation, among others. Oryzon is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Oryzon Genomics S.A.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents 

Table of Contents 2
List of Tables 3
List of Figures 3
Oryzon Genomics S.A. Company Snapshot 4
Oryzon Genomics S.A. Company Overview 4
Key Information 4
Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview 5
Oryzon Genomics S.A. Pipeline Analysis Overview 7
Key Facts 7
Oryzon Genomics S.A. - Major Products and Services 8
Oryzon Genomics S.A. Pipeline Products by Development Stage 9
Oryzon Genomics S.A. Pipeline Products Overview 11
Diagnostic Assay - Alzheimer's Disease 11
Diagnostic Assay - Alzheimer's Disease Product Overview 11
Diagnostic Assay - Parkinson's Disease 12
Diagnostic Assay - Parkinson's Disease Product Overview 12
Diagnostic Assay - Stomach Cancer 13
Diagnostic Assay - Stomach Cancer Product Overview 13
Oryzon Diagnostic Test - Prostate Cancer 14
Oryzon Diagnostic Test - Prostate Cancer Product Overview 14
Oryzon Genomics S.A. - Key Competitors 15
Oryzon Genomics S.A. - Key Employees 16
Oryzon Genomics S.A. - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Oryzon Genomics S.A., Recent Developments 18
Sep 14, 2011: Oryzon Genomics To Launch GynEC Dx Non Invasive Test For Detection Of Endometrial Cancer 18
May 17, 2011: Geadic Biotec Presents Results From Clinical Validation Of GynEC-Dx Test At SSGO 2011 19

Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

Oryzon Genomics S.A., Key Facts 4
Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview 5
Oryzon Genomics S.A. Pipeline Products by Equipment Type 5
Oryzon Genomics S.A. Pipeline Products by Indication 6
Oryzon Genomics S.A., Key Facts 7
Oryzon Genomics S.A., Major Products and Services 8
Oryzon Genomics S.A. Number of Pipeline Products by Development Stage 9
Oryzon Genomics S.A. Pipeline Products Summary by Development Stage 10
Diagnostic Assay - Alzheimer's Disease - Product Status 11
Diagnostic Assay - Alzheimer's Disease - Product Description 11
Diagnostic Assay - Parkinson's Disease - Product Status 12
Diagnostic Assay - Parkinson's Disease - Product Description 12
Diagnostic Assay - Stomach Cancer - Product Status 13
Diagnostic Assay - Stomach Cancer - Product Description 13
Oryzon Diagnostic Test - Prostate Cancer - Product Status 14
Oryzon Diagnostic Test - Prostate Cancer - Product Description 14
Oryzon Genomics S.A., Key Employees 16

Oryzon Genomics S.A. Pipeline Products by Equipment Type 6
Oryzon Genomics S.A. Pipeline Products by Development Stage 9